Steward Partners Investment Advisory, LLC Exelixis, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $9.37 Billion
- Q2 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 3,656 shares of EXEL stock, worth $98,090. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,656
Previous 3,581
2.09%
Holding current value
$98,090
Previous $84,000
2.38%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding EXEL
# of Institutions
460Shares Held
240MCall Options Held
2.04MPut Options Held
1.29M-
Black Rock Inc. New York, NY33.5MShares$899 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.7MShares$796 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA27.1MShares$727 Million2.95% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.2MShares$407 Million0.6% of portfolio
-
State Street Corp Boston, MA12.6MShares$338 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $8.63B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...